Universal Diagnostics is a biomedicine start-up focused on the development of leading edge technologies in metabolomics, genetics and bioinformatics, with the mission to develop a blood test for early detection.
Om arbejdsgiveren
Summer 2012
The seed of Universal Diagnostics (UDX) was born at NASA Ames Park, in Mountain View, California, during the summer of 2012. Following SingularityUniversity’s global challenge to impact positively one billion people, two experienced technology entrepreneurs decided to launch together a bio-medicine start-up with the goal of fighting Humanity’s most important enemy: cancer.
On October 2012
The company was officially incorporated in Spain.
The monumental goal of UDX is to develop a test to detect cancer early, when it still can be cured and save millions of lives.
On June 2013
The company closed a seed round of capital from international investors.
During 2013
UDX started a large-scale research metabolomics project for discovering ex-novo biomarkers for different cancers with high incidence and mortality rate in the world.
During 2014
UDX has established alliances and collaborations with international universities, companies, biobanks and hospitals to validate the technology in all races and populations.
Following clinical trials and regulatory approval, UDX will offer tests for the early diagnostics of the most prevalent cancers.
UDX’s first product is a blood-based test for the early detection of colorectal cancer and polyps, the precursor to colorectal cancer.
Arbejdsgiver placering
Find lignende arbejdsgivere
Interessante artikler
Se relaterede job
Head of Department of Estuarine & Delta Systems Research
NIOZ Royal Netherlands Institute for Sea Research
for 1 uge siden
Teaching Associate in the History of Medicine (Fixed term, Part time)
University of Nottingham
for 1 uge siden